When was RenovoDerm founded?

RenovoDerm was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Where is RenovoDerm located?

RenovoDerm is headquartered in Columbus, United States.

How many employees does RenovoDerm have?

As of Jun 30, 2026, the latest employee count at RenovoDerm is 4.

Is RenovoDerm a funded company?

RenovoDerm is a funded company, having raised a total of $775K across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jun 2017.

When was the latest funding round of RenovoDerm?

RenovoDerm's latest funding was a $***** Conventional Debt round on May 09, 2024, with participation from 0 investor. Its primary sector is Wound Care. In United States, the Wound Care sector has seen $81.2M in funding in 2026 to date.

Where does RenovoDerm rank among its competitors?

RenovoDerm ranks 11th amongst 102 active competitors, of which 29 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Conexeu Sciences, which secured $252K in Sep, 2026.

Who are the top competitors of RenovoDerm?

RenovoDerm's top competitors include Imbed Biosciences, NanoSyrinx and Organogenesis. Among them, Conexeu Sciences secured the most recent funding round in September, 2026.

RenovoDerm - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of nanofiber-based wound care devices. It develops Phoenix Wound Matrix, a nanofiber product that mimics the extracellular matrix found naturally in the body. It can be used for the treatment of pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled or undermined wounds, surgical wounds, and trauma wounds.

Website: www.renovoderm.tech/
Phone Number: +1 **********

Key Metrics

Founded Year

2016

Location

Columbus, United States

Stage

Seed

Total Funding

$775K in 4 rounds

Latest Funding Round

Conventional Debt, May 09, 2024, $*****

Investors

Proton Enterprises & 2 more

Ranked

11^th among 102 active competitors

Employee Count

4 as on Jun 30, 2026

Similar Companies

Imbed Biosciences & 118 more

View RenovoDerm's full profile

RenovoDerm is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
RenovoDerm, LLC CIN: 814676887 , United States, Active	Dec 31, 2015	-	-	-

RenovoDerm has raised a total funding of $775K over 4 rounds. Its first funding round was on Jun 2017. RenovoDerm has 3 institutional investors.

Here is the list of recent funding rounds of RenovoDerm:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 09, 2024	5754287	Conventional Debt	1571172	8559435	9416590	8428467
Jan 25, 2023	5041852	Seed	2161132	9438391	8104590	4420189
Jan 25, 2021	8245772	Seed	8401459	5903054	5146335	8881681

Access funding benchmarks and valuations. Sign up today!

View details of RenovoDerm's funding rounds and investors

RenovoDerm's employee count trend

RenovoDerm has 4 employees as of Jun 26. Here is RenovoDerm's employee count trend over the years:

Uncover RenovoDerm's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of RenovoDerm include Imbed Biosciences, NanoSyrinx and Organogenesis. Here is the list of Top 10 competitors of RenovoDerm, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Imbed Biosciences 2010, Madison (United States), Series C	Provider of nanotech-based wound care products	$34.3M	Niterra, MassChallenge & 7 others	66/100
2nd	NanoSyrinx 2018, Coventry (United Kingdom), Series A	Developer of targeted intracellular delivery platform for biological molecules	$21.6M	Octopus Ventures, M Ventures & 15 others	61/100
3rd	Organogenesis 1985, Canton (United States), Public	Regenerative tissue innovations for advanced wound care and surgical solutions	$30M	Spring St. Group, Eastward Capital Partners ... & 2 others	58/100
4th	Acera Surgical 2013, St. Louis (United States), Acquired	Provider of synthetic electrospun scaffolds for regenerative medical applications	$6.32M	St. Louis Arch Angels, Missouri Technology ... & 1 others	57/100
5th	Cour Pharma 2013, Chicago (United States), Series A	Developer of biotech nano-particles for immune diseases	$135M	Alpha Wave Global, Bristol-Myers Squibb & 6 others	57/100
6th	GeniPhys 2014, Zionsville (United States), Series A	Developer of collagen polymers for tissue regeneration	$13.5M	Elevate Ventures, Plug and Play Tech Center ... & 3 others	53/100
7th	BioTissue 2001, Miami (United States), Series C	Developer of regenerative biologic therapies for eye care	$110M	Ballast Point Ventures, RC Capital & 2 others	52/100
8th	Humanetics Corporation 1988, Minneapolis (United States), Funding Raised	Clinical-stage biopharma company developing radiation modulators as therapeutics for solid cancers	-	Defense.gov, National Heart Lung and Blood Institute ... & 4 others	50/100
9th	BioLab Holdings 2018, Mesa (United States), Unfunded	Manufacturer of synthetic antimicrobial matrices and single, dual, triple layer membranes	-	-	49/100
10th	Conexeu Sciences 2023, Vancouver (Canada), Public	Developer of products for skin restoration and wound care	$6.96M	-	47/100
11th	RenovoDerm 2016, Columbus (United States), Seed	Developer of nanofiber-based wound care devices	$775K	Proton Enterprises, Monte Carlo Capital & 1 others	46/100